The hero ingredient, glutathione, is a brightening antioxidant that reduces the appearance of fine lines and wrinkles
Abstract Recent large clinical trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, with the aim of verifying cardiovascular safety, have revealed that these medications have a preventative advantage on adverse cardiovascular outcomes, including worsening of heart failure and deterioration of nephropathy, in patients with type 2 diabetes (T2D)
GIP -CNS, GIP , Purkinje -olfactory bulb ( Nyberg ' -J Neurosci Res 2007)
Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027
Why Loose Skin Happens After Weight Loss When we gain weight, the skin stretches to accommodate increased fat tissue
Coenzyme Q10 is now CoQ10 Healthy Heart